Global Antipyretic Chinese Traditional Medicine Market Growth 2026-2032
The global Antipyretic Chinese Traditional Medicine market size is predicted to grow from US$ 3189 million in 2025 to US$ 5132 million in 2032; it is expected to grow at a CAGR of 7.1% from 2026 to 2032.
In 2025, global Antipyretic Chinese Traditional Medicine reached approximately 366.2 M Units, with an average global market price of around 8.9 USD/unit.
ntipyretic Chinese Traditional Medicine refers to a category of traditional Chinese medicinal materials and preparations guided by traditional Chinese medicine theory, which are mostly cold in nature and bitter in taste, and mainly function to clear away internal heat, reduce fever and detoxify through ingredients such as flavonoids and alkaloids. It is used to treat various fever symptoms caused by exogenous pathogens, internal heat accumulation or yin deficiency, and can be divided into types such as clearing heat and purging fire, clearing heat and detoxifying, and clearing heat and cooling blood. Common varieties include honeysuckle, chrysanthemum, coptis, and preparations such as Yin Qiao San and Huang Lian Jie Du Tang.
Driven by the policy of traditional Chinese medicine revitalization, the increase in self-medication awareness, and the preference for mild and safe antipyretic products, the demand for antipyretic traditional Chinese medicine shows a steady growth trend. The market scale is expanding year by year, with the OTC channel and online sales channel growing rapidly, and there is a large demand for products for special groups such as children and the elderly. Business opportunities lie in the development of new preparations with high efficiency and convenient administration, the strengthening of quality control and evidence-based medical research, the expansion of international markets, and the development of personalized products and health management services to meet diversified market needs.
LP Information, Inc. (LPI) ' newest research report, the ?Antipyretic Chinese Traditional Medicine Industry Forecast? looks at past sales and reviews total world Antipyretic Chinese Traditional Medicine sales in 2025, providing a comprehensive analysis by region and market sector of projected Antipyretic Chinese Traditional Medicine sales for 2026 through 2032. With Antipyretic Chinese Traditional Medicine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Antipyretic Chinese Traditional Medicine industry.
This Insight Report provides a comprehensive analysis of the global Antipyretic Chinese Traditional Medicine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Antipyretic Chinese Traditional Medicine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Antipyretic Chinese Traditional Medicine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Antipyretic Chinese Traditional Medicine and breaks down the forecast by Dosage Form, by Sales Channel, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Antipyretic Chinese Traditional Medicine.
This report presents a comprehensive overview, market shares, and growth opportunities of Antipyretic Chinese Traditional Medicine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Dosage Form:
In 2025, global Antipyretic Chinese Traditional Medicine reached approximately 366.2 M Units, with an average global market price of around 8.9 USD/unit.
ntipyretic Chinese Traditional Medicine refers to a category of traditional Chinese medicinal materials and preparations guided by traditional Chinese medicine theory, which are mostly cold in nature and bitter in taste, and mainly function to clear away internal heat, reduce fever and detoxify through ingredients such as flavonoids and alkaloids. It is used to treat various fever symptoms caused by exogenous pathogens, internal heat accumulation or yin deficiency, and can be divided into types such as clearing heat and purging fire, clearing heat and detoxifying, and clearing heat and cooling blood. Common varieties include honeysuckle, chrysanthemum, coptis, and preparations such as Yin Qiao San and Huang Lian Jie Du Tang.
Driven by the policy of traditional Chinese medicine revitalization, the increase in self-medication awareness, and the preference for mild and safe antipyretic products, the demand for antipyretic traditional Chinese medicine shows a steady growth trend. The market scale is expanding year by year, with the OTC channel and online sales channel growing rapidly, and there is a large demand for products for special groups such as children and the elderly. Business opportunities lie in the development of new preparations with high efficiency and convenient administration, the strengthening of quality control and evidence-based medical research, the expansion of international markets, and the development of personalized products and health management services to meet diversified market needs.
LP Information, Inc. (LPI) ' newest research report, the ?Antipyretic Chinese Traditional Medicine Industry Forecast? looks at past sales and reviews total world Antipyretic Chinese Traditional Medicine sales in 2025, providing a comprehensive analysis by region and market sector of projected Antipyretic Chinese Traditional Medicine sales for 2026 through 2032. With Antipyretic Chinese Traditional Medicine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Antipyretic Chinese Traditional Medicine industry.
This Insight Report provides a comprehensive analysis of the global Antipyretic Chinese Traditional Medicine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Antipyretic Chinese Traditional Medicine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Antipyretic Chinese Traditional Medicine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Antipyretic Chinese Traditional Medicine and breaks down the forecast by Dosage Form, by Sales Channel, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Antipyretic Chinese Traditional Medicine.
This report presents a comprehensive overview, market shares, and growth opportunities of Antipyretic Chinese Traditional Medicine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Dosage Form:
- Granule
- Capsule
- Tablet
- Oral Liquid
- Injection
- OTC Patent Medicine
- Prescription Patent Medicine
- Heat-Clearing and Detoxifying
- Wind-Heat Releasing
- Exterior-Releasing and Antipyretic
- Damp-Heat Clearing
- Qi and Yin Supporting With Heat Relief
- Online Sales
- Offline Sales
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Langrun
- Hubei Jumpcan Pharmaceutical
- Chasesun Pharmaceutical
- Yangtze River Pharmaceutical
- Jiangsu Kanion Pharmaceutical
- Guangdong Leiyunshang
- Shineway Pharma
- Qingfeng Pharmaceutical
- Jiangxi Prozin Pharmaceutical
- Zhenao Jinyinhua Pharmaceutical
- Shandong Runzhong Pharmaceutical
- Sinopharm Group
- Baiyunshan Mingxing Pharmaceutical
- Guangzhou Pharmaceuticals Corporation
- Yunnan Baiyao
- CR Pharmaceutical Commercial Group
- JiLin FuKang Pharmaceutical
- Zhejiang CONBA Pharmaceutical
- SemBioSys Genetics
- Wecome Pharmaceutica
- Guizhou Bailing Group Pharmaceutica
- Xiuzheng Pharmaceutical
- Taiji
- China Beijing Tong Ren Tang Group Co. Ltd.
- Kunming Pharma
- CR Sanjiu
- Yiling Pharmaceutical
- Tianjin Pharmaceutical Da Ren Tang Group
- Xiangxue Pharmaceutical
- Harbin Pharmaceutical Group
- Fusen Pharmaceutical
- What is the 10-year outlook for the global Antipyretic Chinese Traditional Medicine market?
- What factors are driving Antipyretic Chinese Traditional Medicine market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How doAntipyretic Chinese Traditional Medicine market opportunities vary by end market size?
- How does Antipyretic Chinese Traditional Medicine break out by Dosage Form, by Sales Channel?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Antipyretic Chinese Traditional Medicine Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Antipyretic Chinese Traditional Medicine by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Antipyretic Chinese Traditional Medicine by Country/Region, 2021, 2025 & 2032
2.2 Antipyretic Chinese Traditional Medicine Segment by Dosage Form
2.2.1 Granule
2.2.2 Capsule
2.2.3 Tablet
2.2.4 Oral Liquid
2.2.5 Injection
2.2.6 Antipyretic Chinese Traditional Medicine Sales by Dosage Form
2.2.6.1 Global Antipyretic Chinese Traditional Medicine Sales Market Share by Dosage Form (2021-2026)
2.2.6.2 Global Antipyretic Chinese Traditional Medicine Revenue and Market Share by Dosage Form (2021-2026)
2.2.6.3 Global Antipyretic Chinese Traditional Medicine Sale Price by Dosage Form (2021-2026)
2.3 Antipyretic Chinese Traditional Medicine Segment by Product Attribute
2.3.1 OTC Patent Medicine
2.3.2 Prescription Patent Medicine
2.3.3 Antipyretic Chinese Traditional Medicine Sales by Product Attribute
2.3.3.1 Global Antipyretic Chinese Traditional Medicine Sales Market Share by Product Attribute (2021-2026)
2.3.3.2 Global Antipyretic Chinese Traditional Medicine Revenue and Market Share by Product Attribute (2021-2026)
2.3.3.3 Global Antipyretic Chinese Traditional Medicine Sale Price by Product Attribute (2021-2026)
2.4 Antipyretic Chinese Traditional Medicine Segment by Therapeutic Function
2.4.1 Heat-Clearing and Detoxifying
2.4.2 Wind-Heat Releasing
2.4.3 Exterior-Releasing and Antipyretic
2.4.4 Damp-Heat Clearing
2.4.5 Qi and Yin Supporting With Heat Relief
2.4.6 Antipyretic Chinese Traditional Medicine Sales by Therapeutic Function
2.4.6.1 Global Antipyretic Chinese Traditional Medicine Sales Market Share by Therapeutic Function (2021-2026)
2.4.6.2 Global Antipyretic Chinese Traditional Medicine Revenue and Market Share by Therapeutic Function (2021-2026)
2.4.6.3 Global Antipyretic Chinese Traditional Medicine Sale Price by Therapeutic Function (2021-2026)
2.5 Antipyretic Chinese Traditional Medicine Segment by Sales Channel
2.5.1 Online Sales
2.5.2 Offline Sales
2.5.3 Antipyretic Chinese Traditional Medicine Sales by Sales Channel
2.5.3.1 Global Antipyretic Chinese Traditional Medicine Sale Market Share by Sales Channel (2021-2026)
2.5.3.2 Global Antipyretic Chinese Traditional Medicine Revenue and Market Share by Sales Channel (2021-2026)
2.5.3.3 Global Antipyretic Chinese Traditional Medicine Sale Price by Sales Channel (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Antipyretic Chinese Traditional Medicine Breakdown Data by Company
3.1.1 Global Antipyretic Chinese Traditional Medicine Annual Sales by Company (2021-2026)
3.1.2 Global Antipyretic Chinese Traditional Medicine Sales Market Share by Company (2021-2026)
3.2 Global Antipyretic Chinese Traditional Medicine Annual Revenue by Company (2021-2026)
3.2.1 Global Antipyretic Chinese Traditional Medicine Revenue by Company (2021-2026)
3.2.2 Global Antipyretic Chinese Traditional Medicine Revenue Market Share by Company (2021-2026)
3.3 Global Antipyretic Chinese Traditional Medicine Sale Price by Company
3.4 Key Manufacturers Antipyretic Chinese Traditional Medicine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Antipyretic Chinese Traditional Medicine Product Location Distribution
3.4.2 Players Antipyretic Chinese Traditional Medicine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ANTIPYRETIC CHINESE TRADITIONAL MEDICINE BY GEOGRAPHIC REGION
4.1 World Historic Antipyretic Chinese Traditional Medicine Market Size by Geographic Region (2021-2026)
4.1.1 Global Antipyretic Chinese Traditional Medicine Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Antipyretic Chinese Traditional Medicine Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Antipyretic Chinese Traditional Medicine Market Size by Country/Region (2021-2026)
4.2.1 Global Antipyretic Chinese Traditional Medicine Annual Sales by Country/Region (2021-2026)
4.2.2 Global Antipyretic Chinese Traditional Medicine Annual Revenue by Country/Region (2021-2026)
4.3 Americas Antipyretic Chinese Traditional Medicine Sales Growth
4.4 APAC Antipyretic Chinese Traditional Medicine Sales Growth
4.5 Europe Antipyretic Chinese Traditional Medicine Sales Growth
4.6 Middle East & Africa Antipyretic Chinese Traditional Medicine Sales Growth
5 AMERICAS
5.1 Americas Antipyretic Chinese Traditional Medicine Sales by Country
5.1.1 Americas Antipyretic Chinese Traditional Medicine Sales by Country (2021-2026)
5.1.2 Americas Antipyretic Chinese Traditional Medicine Revenue by Country (2021-2026)
5.2 Americas Antipyretic Chinese Traditional Medicine Sales by Dosage Form (2021-2026)
5.3 Americas Antipyretic Chinese Traditional Medicine Sales by Sales Channel (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Antipyretic Chinese Traditional Medicine Sales by Region
6.1.1 APAC Antipyretic Chinese Traditional Medicine Sales by Region (2021-2026)
6.1.2 APAC Antipyretic Chinese Traditional Medicine Revenue by Region (2021-2026)
6.2 APAC Antipyretic Chinese Traditional Medicine Sales by Dosage Form (2021-2026)
6.3 APAC Antipyretic Chinese Traditional Medicine Sales by Sales Channel (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Antipyretic Chinese Traditional Medicine by Country
7.1.1 Europe Antipyretic Chinese Traditional Medicine Sales by Country (2021-2026)
7.1.2 Europe Antipyretic Chinese Traditional Medicine Revenue by Country (2021-2026)
7.2 Europe Antipyretic Chinese Traditional Medicine Sales by Dosage Form (2021-2026)
7.3 Europe Antipyretic Chinese Traditional Medicine Sales by Sales Channel (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Antipyretic Chinese Traditional Medicine by Country
8.1.1 Middle East & Africa Antipyretic Chinese Traditional Medicine Sales by Country (2021-2026)
8.1.2 Middle East & Africa Antipyretic Chinese Traditional Medicine Revenue by Country (2021-2026)
8.2 Middle East & Africa Antipyretic Chinese Traditional Medicine Sales by Dosage Form (2021-2026)
8.3 Middle East & Africa Antipyretic Chinese Traditional Medicine Sales by Sales Channel (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Antipyretic Chinese Traditional Medicine
10.3 Manufacturing Process Analysis of Antipyretic Chinese Traditional Medicine
10.4 Industry Chain Structure of Antipyretic Chinese Traditional Medicine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Antipyretic Chinese Traditional Medicine Distributors
11.3 Antipyretic Chinese Traditional Medicine Customer
12 WORLD FORECAST REVIEW FOR ANTIPYRETIC CHINESE TRADITIONAL MEDICINE BY GEOGRAPHIC REGION
12.1 Global Antipyretic Chinese Traditional Medicine Market Size Forecast by Region
12.1.1 Global Antipyretic Chinese Traditional Medicine Forecast by Region (2027-2032)
12.1.2 Global Antipyretic Chinese Traditional Medicine Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Antipyretic Chinese Traditional Medicine Forecast by Dosage Form (2027-2032)
12.7 Global Antipyretic Chinese Traditional Medicine Forecast by Sales Channel (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Langrun
13.1.1 Langrun Company Information
13.1.2 Langrun Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
13.1.3 Langrun Antipyretic Chinese Traditional Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Langrun Main Business Overview
13.1.5 Langrun Latest Developments
13.2 Hubei Jumpcan Pharmaceutical
13.2.1 Hubei Jumpcan Pharmaceutical Company Information
13.2.2 Hubei Jumpcan Pharmaceutical Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
13.2.3 Hubei Jumpcan Pharmaceutical Antipyretic Chinese Traditional Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Hubei Jumpcan Pharmaceutical Main Business Overview
13.2.5 Hubei Jumpcan Pharmaceutical Latest Developments
13.3 Chasesun Pharmaceutical
13.3.1 Chasesun Pharmaceutical Company Information
13.3.2 Chasesun Pharmaceutical Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
13.3.3 Chasesun Pharmaceutical Antipyretic Chinese Traditional Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Chasesun Pharmaceutical Main Business Overview
13.3.5 Chasesun Pharmaceutical Latest Developments
13.4 Yangtze River Pharmaceutical
13.4.1 Yangtze River Pharmaceutical Company Information
13.4.2 Yangtze River Pharmaceutical Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
13.4.3 Yangtze River Pharmaceutical Antipyretic Chinese Traditional Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Yangtze River Pharmaceutical Main Business Overview
13.4.5 Yangtze River Pharmaceutical Latest Developments
13.5 Jiangsu Kanion Pharmaceutical
13.5.1 Jiangsu Kanion Pharmaceutical Company Information
13.5.2 Jiangsu Kanion Pharmaceutical Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
13.5.3 Jiangsu Kanion Pharmaceutical Antipyretic Chinese Traditional Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Jiangsu Kanion Pharmaceutical Main Business Overview
13.5.5 Jiangsu Kanion Pharmaceutical Latest Developments
13.6 Guangdong Leiyunshang
13.6.1 Guangdong Leiyunshang Company Information
13.6.2 Guangdong Leiyunshang Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
13.6.3 Guangdong Leiyunshang Antipyretic Chinese Traditional Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Guangdong Leiyunshang Main Business Overview
13.6.5 Guangdong Leiyunshang Latest Developments
13.7 Shineway Pharma
13.7.1 Shineway Pharma Company Information
13.7.2 Shineway Pharma Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
13.7.3 Shineway Pharma Antipyretic Chinese Traditional Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Shineway Pharma Main Business Overview
13.7.5 Shineway Pharma Latest Developments
13.8 Qingfeng Pharmaceutical
13.8.1 Qingfeng Pharmaceutical Company Information
13.8.2 Qingfeng Pharmaceutical Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
13.8.3 Qingfeng Pharmaceutical Antipyretic Chinese Traditional Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Qingfeng Pharmaceutical Main Business Overview
13.8.5 Qingfeng Pharmaceutical Latest Developments
13.9 Jiangxi Prozin Pharmaceutical
13.9.1 Jiangxi Prozin Pharmaceutical Company Information
13.9.2 Jiangxi Prozin Pharmaceutical Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
13.9.3 Jiangxi Prozin Pharmaceutical Antipyretic Chinese Traditional Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Jiangxi Prozin Pharmaceutical Main Business Overview
13.9.5 Jiangxi Prozin Pharmaceutical Latest Developments
13.10 Zhenao Jinyinhua Pharmaceutical
13.10.1 Zhenao Jinyinhua Pharmaceutical Company Information
13.10.2 Zhenao Jinyinhua Pharmaceutical Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
13.10.3 Zhenao Jinyinhua Pharmaceutical Antipyretic Chinese Traditional Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Zhenao Jinyinhua Pharmaceutical Main Business Overview
13.10.5 Zhenao Jinyinhua Pharmaceutical Latest Developments
13.11 Shandong Runzhong Pharmaceutical
13.11.1 Shandong Runzhong Pharmaceutical Company Information
13.11.2 Shandong Runzhong Pharmaceutical Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
13.11.3 Shandong Runzhong Pharmaceutical Antipyretic Chinese Traditional Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Shandong Runzhong Pharmaceutical Main Business Overview
13.11.5 Shandong Runzhong Pharmaceutical Latest Developments
13.12 Sinopharm Group
13.12.1 Sinopharm Group Company Information
13.12.2 Sinopharm Group Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
13.12.3 Sinopharm Group Antipyretic Chinese Traditional Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Sinopharm Group Main Business Overview
13.12.5 Sinopharm Group Latest Developments
13.13 Baiyunshan Mingxing Pharmaceutical
13.13.1 Baiyunshan Mingxing Pharmaceutical Company Information
13.13.2 Baiyunshan Mingxing Pharmaceutical Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
13.13.3 Baiyunshan Mingxing Pharmaceutical Antipyretic Chinese Traditional Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Baiyunshan Mingxing Pharmaceutical Main Business Overview
13.13.5 Baiyunshan Mingxing Pharmaceutical Latest Developments
13.14 Guangzhou Pharmaceuticals Corporation
13.14.1 Guangzhou Pharmaceuticals Corporation Company Information
13.14.2 Guangzhou Pharmaceuticals Corporation Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
13.14.3 Guangzhou Pharmaceuticals Corporation Antipyretic Chinese Traditional Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Guangzhou Pharmaceuticals Corporation Main Business Overview
13.14.5 Guangzhou Pharmaceuticals Corporation Latest Developments
13.15 Yunnan Baiyao
13.15.1 Yunnan Baiyao Company Information
13.15.2 Yunnan Baiyao Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
13.15.3 Yunnan Baiyao Antipyretic Chinese Traditional Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Yunnan Baiyao Main Business Overview
13.15.5 Yunnan Baiyao Latest Developments
13.16 CR Pharmaceutical Commercial Group
13.16.1 CR Pharmaceutical Commercial Group Company Information
13.16.2 CR Pharmaceutical Commercial Group Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
13.16.3 CR Pharmaceutical Commercial Group Antipyretic Chinese Traditional Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 CR Pharmaceutical Commercial Group Main Business Overview
13.16.5 CR Pharmaceutical Commercial Group Latest Developments
13.17 JiLin FuKang Pharmaceutical
13.17.1 JiLin FuKang Pharmaceutical Company Information
13.17.2 JiLin FuKang Pharmaceutical Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
13.17.3 JiLin FuKang Pharmaceutical Antipyretic Chinese Traditional Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 JiLin FuKang Pharmaceutical Main Business Overview
13.17.5 JiLin FuKang Pharmaceutical Latest Developments
13.18 Zhejiang CONBA Pharmaceutical
13.18.1 Zhejiang CONBA Pharmaceutical Company Information
13.18.2 Zhejiang CONBA Pharmaceutical Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
13.18.3 Zhejiang CONBA Pharmaceutical Antipyretic Chinese Traditional Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Zhejiang CONBA Pharmaceutical Main Business Overview
13.18.5 Zhejiang CONBA Pharmaceutical Latest Developments
13.19 SemBioSys Genetics
13.19.1 SemBioSys Genetics Company Information
13.19.2 SemBioSys Genetics Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
13.19.3 SemBioSys Genetics Antipyretic Chinese Traditional Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 SemBioSys Genetics Main Business Overview
13.19.5 SemBioSys Genetics Latest Developments
13.20 Wecome Pharmaceutica
13.20.1 Wecome Pharmaceutica Company Information
13.20.2 Wecome Pharmaceutica Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
13.20.3 Wecome Pharmaceutica Antipyretic Chinese Traditional Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.20.4 Wecome Pharmaceutica Main Business Overview
13.20.5 Wecome Pharmaceutica Latest Developments
13.21 Guizhou Bailing Group Pharmaceutica
13.21.1 Guizhou Bailing Group Pharmaceutica Company Information
13.21.2 Guizhou Bailing Group Pharmaceutica Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
13.21.3 Guizhou Bailing Group Pharmaceutica Antipyretic Chinese Traditional Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.21.4 Guizhou Bailing Group Pharmaceutica Main Business Overview
13.21.5 Guizhou Bailing Group Pharmaceutica Latest Developments
13.22 Xiuzheng Pharmaceutical
13.22.1 Xiuzheng Pharmaceutical Company Information
13.22.2 Xiuzheng Pharmaceutical Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
13.22.3 Xiuzheng Pharmaceutical Antipyretic Chinese Traditional Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.22.4 Xiuzheng Pharmaceutical Main Business Overview
13.22.5 Xiuzheng Pharmaceutical Latest Developments
13.23 Taiji
13.23.1 Taiji Company Information
13.23.2 Taiji Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
13.23.3 Taiji Antipyretic Chinese Traditional Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.23.4 Taiji Main Business Overview
13.23.5 Taiji Latest Developments
13.24 China Beijing Tong Ren Tang Group Co. Ltd.
13.24.1 China Beijing Tong Ren Tang Group Co. Ltd. Company Information
13.24.2 China Beijing Tong Ren Tang Group Co. Ltd. Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
13.24.3 China Beijing Tong Ren Tang Group Co. Ltd. Antipyretic Chinese Traditional Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.24.4 China Beijing Tong Ren Tang Group Co. Ltd. Main Business Overview
13.24.5 China Beijing Tong Ren Tang Group Co. Ltd. Latest Developments
13.25 Kunming Pharma
13.25.1 Kunming Pharma Company Information
13.25.2 Kunming Pharma Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
13.25.3 Kunming Pharma Antipyretic Chinese Traditional Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.25.4 Kunming Pharma Main Business Overview
13.25.5 Kunming Pharma Latest Developments
13.26 CR Sanjiu
13.26.1 CR Sanjiu Company Information
13.26.2 CR Sanjiu Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
13.26.3 CR Sanjiu Antipyretic Chinese Traditional Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.26.4 CR Sanjiu Main Business Overview
13.26.5 CR Sanjiu Latest Developments
13.27 Yiling Pharmaceutical
13.27.1 Yiling Pharmaceutical Company Information
13.27.2 Yiling Pharmaceutical Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
13.27.3 Yiling Pharmaceutical Antipyretic Chinese Traditional Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.27.4 Yiling Pharmaceutical Main Business Overview
13.27.5 Yiling Pharmaceutical Latest Developments
13.28 Tianjin Pharmaceutical Da Ren Tang Group
13.28.1 Tianjin Pharmaceutical Da Ren Tang Group Company Information
13.28.2 Tianjin Pharmaceutical Da Ren Tang Group Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
13.28.3 Tianjin Pharmaceutical Da Ren Tang Group Antipyretic Chinese Traditional Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.28.4 Tianjin Pharmaceutical Da Ren Tang Group Main Business Overview
13.28.5 Tianjin Pharmaceutical Da Ren Tang Group Latest Developments
13.29 Xiangxue Pharmaceutical
13.29.1 Xiangxue Pharmaceutical Company Information
13.29.2 Xiangxue Pharmaceutical Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
13.29.3 Xiangxue Pharmaceutical Antipyretic Chinese Traditional Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.29.4 Xiangxue Pharmaceutical Main Business Overview
13.29.5 Xiangxue Pharmaceutical Latest Developments
13.30 Harbin Pharmaceutical Group
13.30.1 Harbin Pharmaceutical Group Company Information
13.30.2 Harbin Pharmaceutical Group Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
13.30.3 Harbin Pharmaceutical Group Antipyretic Chinese Traditional Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.30.4 Harbin Pharmaceutical Group Main Business Overview
13.30.5 Harbin Pharmaceutical Group Latest Developments
13.31 Fusen Pharmaceutical
13.31.1 Fusen Pharmaceutical Company Information
13.31.2 Fusen Pharmaceutical Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
13.31.3 Fusen Pharmaceutical Antipyretic Chinese Traditional Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.31.4 Fusen Pharmaceutical Main Business Overview
13.31.5 Fusen Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Antipyretic Chinese Traditional Medicine Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Antipyretic Chinese Traditional Medicine by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Antipyretic Chinese Traditional Medicine by Country/Region, 2021, 2025 & 2032
2.2 Antipyretic Chinese Traditional Medicine Segment by Dosage Form
2.2.1 Granule
2.2.2 Capsule
2.2.3 Tablet
2.2.4 Oral Liquid
2.2.5 Injection
2.2.6 Antipyretic Chinese Traditional Medicine Sales by Dosage Form
2.2.6.1 Global Antipyretic Chinese Traditional Medicine Sales Market Share by Dosage Form (2021-2026)
2.2.6.2 Global Antipyretic Chinese Traditional Medicine Revenue and Market Share by Dosage Form (2021-2026)
2.2.6.3 Global Antipyretic Chinese Traditional Medicine Sale Price by Dosage Form (2021-2026)
2.3 Antipyretic Chinese Traditional Medicine Segment by Product Attribute
2.3.1 OTC Patent Medicine
2.3.2 Prescription Patent Medicine
2.3.3 Antipyretic Chinese Traditional Medicine Sales by Product Attribute
2.3.3.1 Global Antipyretic Chinese Traditional Medicine Sales Market Share by Product Attribute (2021-2026)
2.3.3.2 Global Antipyretic Chinese Traditional Medicine Revenue and Market Share by Product Attribute (2021-2026)
2.3.3.3 Global Antipyretic Chinese Traditional Medicine Sale Price by Product Attribute (2021-2026)
2.4 Antipyretic Chinese Traditional Medicine Segment by Therapeutic Function
2.4.1 Heat-Clearing and Detoxifying
2.4.2 Wind-Heat Releasing
2.4.3 Exterior-Releasing and Antipyretic
2.4.4 Damp-Heat Clearing
2.4.5 Qi and Yin Supporting With Heat Relief
2.4.6 Antipyretic Chinese Traditional Medicine Sales by Therapeutic Function
2.4.6.1 Global Antipyretic Chinese Traditional Medicine Sales Market Share by Therapeutic Function (2021-2026)
2.4.6.2 Global Antipyretic Chinese Traditional Medicine Revenue and Market Share by Therapeutic Function (2021-2026)
2.4.6.3 Global Antipyretic Chinese Traditional Medicine Sale Price by Therapeutic Function (2021-2026)
2.5 Antipyretic Chinese Traditional Medicine Segment by Sales Channel
2.5.1 Online Sales
2.5.2 Offline Sales
2.5.3 Antipyretic Chinese Traditional Medicine Sales by Sales Channel
2.5.3.1 Global Antipyretic Chinese Traditional Medicine Sale Market Share by Sales Channel (2021-2026)
2.5.3.2 Global Antipyretic Chinese Traditional Medicine Revenue and Market Share by Sales Channel (2021-2026)
2.5.3.3 Global Antipyretic Chinese Traditional Medicine Sale Price by Sales Channel (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Antipyretic Chinese Traditional Medicine Breakdown Data by Company
3.1.1 Global Antipyretic Chinese Traditional Medicine Annual Sales by Company (2021-2026)
3.1.2 Global Antipyretic Chinese Traditional Medicine Sales Market Share by Company (2021-2026)
3.2 Global Antipyretic Chinese Traditional Medicine Annual Revenue by Company (2021-2026)
3.2.1 Global Antipyretic Chinese Traditional Medicine Revenue by Company (2021-2026)
3.2.2 Global Antipyretic Chinese Traditional Medicine Revenue Market Share by Company (2021-2026)
3.3 Global Antipyretic Chinese Traditional Medicine Sale Price by Company
3.4 Key Manufacturers Antipyretic Chinese Traditional Medicine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Antipyretic Chinese Traditional Medicine Product Location Distribution
3.4.2 Players Antipyretic Chinese Traditional Medicine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ANTIPYRETIC CHINESE TRADITIONAL MEDICINE BY GEOGRAPHIC REGION
4.1 World Historic Antipyretic Chinese Traditional Medicine Market Size by Geographic Region (2021-2026)
4.1.1 Global Antipyretic Chinese Traditional Medicine Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Antipyretic Chinese Traditional Medicine Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Antipyretic Chinese Traditional Medicine Market Size by Country/Region (2021-2026)
4.2.1 Global Antipyretic Chinese Traditional Medicine Annual Sales by Country/Region (2021-2026)
4.2.2 Global Antipyretic Chinese Traditional Medicine Annual Revenue by Country/Region (2021-2026)
4.3 Americas Antipyretic Chinese Traditional Medicine Sales Growth
4.4 APAC Antipyretic Chinese Traditional Medicine Sales Growth
4.5 Europe Antipyretic Chinese Traditional Medicine Sales Growth
4.6 Middle East & Africa Antipyretic Chinese Traditional Medicine Sales Growth
5 AMERICAS
5.1 Americas Antipyretic Chinese Traditional Medicine Sales by Country
5.1.1 Americas Antipyretic Chinese Traditional Medicine Sales by Country (2021-2026)
5.1.2 Americas Antipyretic Chinese Traditional Medicine Revenue by Country (2021-2026)
5.2 Americas Antipyretic Chinese Traditional Medicine Sales by Dosage Form (2021-2026)
5.3 Americas Antipyretic Chinese Traditional Medicine Sales by Sales Channel (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Antipyretic Chinese Traditional Medicine Sales by Region
6.1.1 APAC Antipyretic Chinese Traditional Medicine Sales by Region (2021-2026)
6.1.2 APAC Antipyretic Chinese Traditional Medicine Revenue by Region (2021-2026)
6.2 APAC Antipyretic Chinese Traditional Medicine Sales by Dosage Form (2021-2026)
6.3 APAC Antipyretic Chinese Traditional Medicine Sales by Sales Channel (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Antipyretic Chinese Traditional Medicine by Country
7.1.1 Europe Antipyretic Chinese Traditional Medicine Sales by Country (2021-2026)
7.1.2 Europe Antipyretic Chinese Traditional Medicine Revenue by Country (2021-2026)
7.2 Europe Antipyretic Chinese Traditional Medicine Sales by Dosage Form (2021-2026)
7.3 Europe Antipyretic Chinese Traditional Medicine Sales by Sales Channel (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Antipyretic Chinese Traditional Medicine by Country
8.1.1 Middle East & Africa Antipyretic Chinese Traditional Medicine Sales by Country (2021-2026)
8.1.2 Middle East & Africa Antipyretic Chinese Traditional Medicine Revenue by Country (2021-2026)
8.2 Middle East & Africa Antipyretic Chinese Traditional Medicine Sales by Dosage Form (2021-2026)
8.3 Middle East & Africa Antipyretic Chinese Traditional Medicine Sales by Sales Channel (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Antipyretic Chinese Traditional Medicine
10.3 Manufacturing Process Analysis of Antipyretic Chinese Traditional Medicine
10.4 Industry Chain Structure of Antipyretic Chinese Traditional Medicine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Antipyretic Chinese Traditional Medicine Distributors
11.3 Antipyretic Chinese Traditional Medicine Customer
12 WORLD FORECAST REVIEW FOR ANTIPYRETIC CHINESE TRADITIONAL MEDICINE BY GEOGRAPHIC REGION
12.1 Global Antipyretic Chinese Traditional Medicine Market Size Forecast by Region
12.1.1 Global Antipyretic Chinese Traditional Medicine Forecast by Region (2027-2032)
12.1.2 Global Antipyretic Chinese Traditional Medicine Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Antipyretic Chinese Traditional Medicine Forecast by Dosage Form (2027-2032)
12.7 Global Antipyretic Chinese Traditional Medicine Forecast by Sales Channel (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Langrun
13.1.1 Langrun Company Information
13.1.2 Langrun Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
13.1.3 Langrun Antipyretic Chinese Traditional Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Langrun Main Business Overview
13.1.5 Langrun Latest Developments
13.2 Hubei Jumpcan Pharmaceutical
13.2.1 Hubei Jumpcan Pharmaceutical Company Information
13.2.2 Hubei Jumpcan Pharmaceutical Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
13.2.3 Hubei Jumpcan Pharmaceutical Antipyretic Chinese Traditional Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Hubei Jumpcan Pharmaceutical Main Business Overview
13.2.5 Hubei Jumpcan Pharmaceutical Latest Developments
13.3 Chasesun Pharmaceutical
13.3.1 Chasesun Pharmaceutical Company Information
13.3.2 Chasesun Pharmaceutical Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
13.3.3 Chasesun Pharmaceutical Antipyretic Chinese Traditional Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Chasesun Pharmaceutical Main Business Overview
13.3.5 Chasesun Pharmaceutical Latest Developments
13.4 Yangtze River Pharmaceutical
13.4.1 Yangtze River Pharmaceutical Company Information
13.4.2 Yangtze River Pharmaceutical Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
13.4.3 Yangtze River Pharmaceutical Antipyretic Chinese Traditional Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Yangtze River Pharmaceutical Main Business Overview
13.4.5 Yangtze River Pharmaceutical Latest Developments
13.5 Jiangsu Kanion Pharmaceutical
13.5.1 Jiangsu Kanion Pharmaceutical Company Information
13.5.2 Jiangsu Kanion Pharmaceutical Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
13.5.3 Jiangsu Kanion Pharmaceutical Antipyretic Chinese Traditional Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Jiangsu Kanion Pharmaceutical Main Business Overview
13.5.5 Jiangsu Kanion Pharmaceutical Latest Developments
13.6 Guangdong Leiyunshang
13.6.1 Guangdong Leiyunshang Company Information
13.6.2 Guangdong Leiyunshang Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
13.6.3 Guangdong Leiyunshang Antipyretic Chinese Traditional Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Guangdong Leiyunshang Main Business Overview
13.6.5 Guangdong Leiyunshang Latest Developments
13.7 Shineway Pharma
13.7.1 Shineway Pharma Company Information
13.7.2 Shineway Pharma Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
13.7.3 Shineway Pharma Antipyretic Chinese Traditional Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Shineway Pharma Main Business Overview
13.7.5 Shineway Pharma Latest Developments
13.8 Qingfeng Pharmaceutical
13.8.1 Qingfeng Pharmaceutical Company Information
13.8.2 Qingfeng Pharmaceutical Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
13.8.3 Qingfeng Pharmaceutical Antipyretic Chinese Traditional Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Qingfeng Pharmaceutical Main Business Overview
13.8.5 Qingfeng Pharmaceutical Latest Developments
13.9 Jiangxi Prozin Pharmaceutical
13.9.1 Jiangxi Prozin Pharmaceutical Company Information
13.9.2 Jiangxi Prozin Pharmaceutical Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
13.9.3 Jiangxi Prozin Pharmaceutical Antipyretic Chinese Traditional Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Jiangxi Prozin Pharmaceutical Main Business Overview
13.9.5 Jiangxi Prozin Pharmaceutical Latest Developments
13.10 Zhenao Jinyinhua Pharmaceutical
13.10.1 Zhenao Jinyinhua Pharmaceutical Company Information
13.10.2 Zhenao Jinyinhua Pharmaceutical Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
13.10.3 Zhenao Jinyinhua Pharmaceutical Antipyretic Chinese Traditional Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Zhenao Jinyinhua Pharmaceutical Main Business Overview
13.10.5 Zhenao Jinyinhua Pharmaceutical Latest Developments
13.11 Shandong Runzhong Pharmaceutical
13.11.1 Shandong Runzhong Pharmaceutical Company Information
13.11.2 Shandong Runzhong Pharmaceutical Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
13.11.3 Shandong Runzhong Pharmaceutical Antipyretic Chinese Traditional Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Shandong Runzhong Pharmaceutical Main Business Overview
13.11.5 Shandong Runzhong Pharmaceutical Latest Developments
13.12 Sinopharm Group
13.12.1 Sinopharm Group Company Information
13.12.2 Sinopharm Group Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
13.12.3 Sinopharm Group Antipyretic Chinese Traditional Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Sinopharm Group Main Business Overview
13.12.5 Sinopharm Group Latest Developments
13.13 Baiyunshan Mingxing Pharmaceutical
13.13.1 Baiyunshan Mingxing Pharmaceutical Company Information
13.13.2 Baiyunshan Mingxing Pharmaceutical Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
13.13.3 Baiyunshan Mingxing Pharmaceutical Antipyretic Chinese Traditional Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Baiyunshan Mingxing Pharmaceutical Main Business Overview
13.13.5 Baiyunshan Mingxing Pharmaceutical Latest Developments
13.14 Guangzhou Pharmaceuticals Corporation
13.14.1 Guangzhou Pharmaceuticals Corporation Company Information
13.14.2 Guangzhou Pharmaceuticals Corporation Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
13.14.3 Guangzhou Pharmaceuticals Corporation Antipyretic Chinese Traditional Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Guangzhou Pharmaceuticals Corporation Main Business Overview
13.14.5 Guangzhou Pharmaceuticals Corporation Latest Developments
13.15 Yunnan Baiyao
13.15.1 Yunnan Baiyao Company Information
13.15.2 Yunnan Baiyao Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
13.15.3 Yunnan Baiyao Antipyretic Chinese Traditional Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Yunnan Baiyao Main Business Overview
13.15.5 Yunnan Baiyao Latest Developments
13.16 CR Pharmaceutical Commercial Group
13.16.1 CR Pharmaceutical Commercial Group Company Information
13.16.2 CR Pharmaceutical Commercial Group Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
13.16.3 CR Pharmaceutical Commercial Group Antipyretic Chinese Traditional Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 CR Pharmaceutical Commercial Group Main Business Overview
13.16.5 CR Pharmaceutical Commercial Group Latest Developments
13.17 JiLin FuKang Pharmaceutical
13.17.1 JiLin FuKang Pharmaceutical Company Information
13.17.2 JiLin FuKang Pharmaceutical Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
13.17.3 JiLin FuKang Pharmaceutical Antipyretic Chinese Traditional Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 JiLin FuKang Pharmaceutical Main Business Overview
13.17.5 JiLin FuKang Pharmaceutical Latest Developments
13.18 Zhejiang CONBA Pharmaceutical
13.18.1 Zhejiang CONBA Pharmaceutical Company Information
13.18.2 Zhejiang CONBA Pharmaceutical Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
13.18.3 Zhejiang CONBA Pharmaceutical Antipyretic Chinese Traditional Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Zhejiang CONBA Pharmaceutical Main Business Overview
13.18.5 Zhejiang CONBA Pharmaceutical Latest Developments
13.19 SemBioSys Genetics
13.19.1 SemBioSys Genetics Company Information
13.19.2 SemBioSys Genetics Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
13.19.3 SemBioSys Genetics Antipyretic Chinese Traditional Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 SemBioSys Genetics Main Business Overview
13.19.5 SemBioSys Genetics Latest Developments
13.20 Wecome Pharmaceutica
13.20.1 Wecome Pharmaceutica Company Information
13.20.2 Wecome Pharmaceutica Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
13.20.3 Wecome Pharmaceutica Antipyretic Chinese Traditional Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.20.4 Wecome Pharmaceutica Main Business Overview
13.20.5 Wecome Pharmaceutica Latest Developments
13.21 Guizhou Bailing Group Pharmaceutica
13.21.1 Guizhou Bailing Group Pharmaceutica Company Information
13.21.2 Guizhou Bailing Group Pharmaceutica Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
13.21.3 Guizhou Bailing Group Pharmaceutica Antipyretic Chinese Traditional Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.21.4 Guizhou Bailing Group Pharmaceutica Main Business Overview
13.21.5 Guizhou Bailing Group Pharmaceutica Latest Developments
13.22 Xiuzheng Pharmaceutical
13.22.1 Xiuzheng Pharmaceutical Company Information
13.22.2 Xiuzheng Pharmaceutical Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
13.22.3 Xiuzheng Pharmaceutical Antipyretic Chinese Traditional Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.22.4 Xiuzheng Pharmaceutical Main Business Overview
13.22.5 Xiuzheng Pharmaceutical Latest Developments
13.23 Taiji
13.23.1 Taiji Company Information
13.23.2 Taiji Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
13.23.3 Taiji Antipyretic Chinese Traditional Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.23.4 Taiji Main Business Overview
13.23.5 Taiji Latest Developments
13.24 China Beijing Tong Ren Tang Group Co. Ltd.
13.24.1 China Beijing Tong Ren Tang Group Co. Ltd. Company Information
13.24.2 China Beijing Tong Ren Tang Group Co. Ltd. Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
13.24.3 China Beijing Tong Ren Tang Group Co. Ltd. Antipyretic Chinese Traditional Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.24.4 China Beijing Tong Ren Tang Group Co. Ltd. Main Business Overview
13.24.5 China Beijing Tong Ren Tang Group Co. Ltd. Latest Developments
13.25 Kunming Pharma
13.25.1 Kunming Pharma Company Information
13.25.2 Kunming Pharma Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
13.25.3 Kunming Pharma Antipyretic Chinese Traditional Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.25.4 Kunming Pharma Main Business Overview
13.25.5 Kunming Pharma Latest Developments
13.26 CR Sanjiu
13.26.1 CR Sanjiu Company Information
13.26.2 CR Sanjiu Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
13.26.3 CR Sanjiu Antipyretic Chinese Traditional Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.26.4 CR Sanjiu Main Business Overview
13.26.5 CR Sanjiu Latest Developments
13.27 Yiling Pharmaceutical
13.27.1 Yiling Pharmaceutical Company Information
13.27.2 Yiling Pharmaceutical Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
13.27.3 Yiling Pharmaceutical Antipyretic Chinese Traditional Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.27.4 Yiling Pharmaceutical Main Business Overview
13.27.5 Yiling Pharmaceutical Latest Developments
13.28 Tianjin Pharmaceutical Da Ren Tang Group
13.28.1 Tianjin Pharmaceutical Da Ren Tang Group Company Information
13.28.2 Tianjin Pharmaceutical Da Ren Tang Group Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
13.28.3 Tianjin Pharmaceutical Da Ren Tang Group Antipyretic Chinese Traditional Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.28.4 Tianjin Pharmaceutical Da Ren Tang Group Main Business Overview
13.28.5 Tianjin Pharmaceutical Da Ren Tang Group Latest Developments
13.29 Xiangxue Pharmaceutical
13.29.1 Xiangxue Pharmaceutical Company Information
13.29.2 Xiangxue Pharmaceutical Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
13.29.3 Xiangxue Pharmaceutical Antipyretic Chinese Traditional Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.29.4 Xiangxue Pharmaceutical Main Business Overview
13.29.5 Xiangxue Pharmaceutical Latest Developments
13.30 Harbin Pharmaceutical Group
13.30.1 Harbin Pharmaceutical Group Company Information
13.30.2 Harbin Pharmaceutical Group Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
13.30.3 Harbin Pharmaceutical Group Antipyretic Chinese Traditional Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.30.4 Harbin Pharmaceutical Group Main Business Overview
13.30.5 Harbin Pharmaceutical Group Latest Developments
13.31 Fusen Pharmaceutical
13.31.1 Fusen Pharmaceutical Company Information
13.31.2 Fusen Pharmaceutical Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
13.31.3 Fusen Pharmaceutical Antipyretic Chinese Traditional Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.31.4 Fusen Pharmaceutical Main Business Overview
13.31.5 Fusen Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Antipyretic Chinese Traditional Medicine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Antipyretic Chinese Traditional Medicine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Granule
Table 4. Major Players of Capsule
Table 5. Major Players of Tablet
Table 6. Major Players of Oral Liquid
Table 7. Major Players of Injection
Table 8. Global Antipyretic Chinese Traditional Medicine Sales by Dosage Form (2021-2026) & (M Units)
Table 9. Global Antipyretic Chinese Traditional Medicine Sales Market Share by Dosage Form (2021-2026)
Table 10. Global Antipyretic Chinese Traditional Medicine Revenue by Dosage Form (2021-2026) & ($ million)
Table 11. Global Antipyretic Chinese Traditional Medicine Revenue Market Share by Dosage Form (2021-2026)
Table 12. Global Antipyretic Chinese Traditional Medicine Sale Price by Dosage Form (2021-2026) & (US$/Unit)
Table 13. Major Players of OTC Patent Medicine
Table 14. Major Players of Prescription Patent Medicine
Table 15. Global Antipyretic Chinese Traditional Medicine Sales by Product Attribute (2021-2026) & (M Units)
Table 16. Global Antipyretic Chinese Traditional Medicine Sales Market Share by Product Attribute (2021-2026)
Table 17. Global Antipyretic Chinese Traditional Medicine Revenue by Product Attribute (2021-2026) & ($ million)
Table 18. Global Antipyretic Chinese Traditional Medicine Revenue Market Share by Product Attribute (2021-2026)
Table 19. Global Antipyretic Chinese Traditional Medicine Sale Price by Product Attribute (2021-2026) & (US$/Unit)
Table 20. Major Players of Heat-Clearing and Detoxifying
Table 21. Major Players of Wind-Heat Releasing
Table 22. Major Players of Exterior-Releasing and Antipyretic
Table 23. Major Players of Damp-Heat Clearing
Table 24. Major Players of Qi and Yin Supporting With Heat Relief
Table 25. Global Antipyretic Chinese Traditional Medicine Sales by Therapeutic Function (2021-2026) & (M Units)
Table 26. Global Antipyretic Chinese Traditional Medicine Sales Market Share by Therapeutic Function (2021-2026)
Table 27. Global Antipyretic Chinese Traditional Medicine Revenue by Therapeutic Function (2021-2026) & ($ million)
Table 28. Global Antipyretic Chinese Traditional Medicine Revenue Market Share by Therapeutic Function (2021-2026)
Table 29. Global Antipyretic Chinese Traditional Medicine Sale Price by Therapeutic Function (2021-2026) & (US$/Unit)
Table 30. Global Antipyretic Chinese Traditional Medicine Sale by Sales Channel (2021-2026) & (M Units)
Table 31. Global Antipyretic Chinese Traditional Medicine Sale Market Share by Sales Channel (2021-2026)
Table 32. Global Antipyretic Chinese Traditional Medicine Revenue by Sales Channel (2021-2026) & ($ million)
Table 33. Global Antipyretic Chinese Traditional Medicine Revenue Market Share by Sales Channel (2021-2026)
Table 34. Global Antipyretic Chinese Traditional Medicine Sale Price by Sales Channel (2021-2026) & (US$/Unit)
Table 35. Global Antipyretic Chinese Traditional Medicine Sales by Company (2021-2026) & (M Units)
Table 36. Global Antipyretic Chinese Traditional Medicine Sales Market Share by Company (2021-2026)
Table 37. Global Antipyretic Chinese Traditional Medicine Revenue by Company (2021-2026) & ($ millions)
Table 38. Global Antipyretic Chinese Traditional Medicine Revenue Market Share by Company (2021-2026)
Table 39. Global Antipyretic Chinese Traditional Medicine Sale Price by Company (2021-2026) & (US$/Unit)
Table 40. Key Manufacturers Antipyretic Chinese Traditional Medicine Producing Area Distribution and Sales Area
Table 41. Players Antipyretic Chinese Traditional Medicine Products Offered
Table 42. Antipyretic Chinese Traditional Medicine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 43. New Products and Potential Entrants
Table 44. Market M&A Activity & Strategy
Table 45. Global Antipyretic Chinese Traditional Medicine Sales by Geographic Region (2021-2026) & (M Units)
Table 46. Global Antipyretic Chinese Traditional Medicine Sales Market Share Geographic Region (2021-2026)
Table 47. Global Antipyretic Chinese Traditional Medicine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 48. Global Antipyretic Chinese Traditional Medicine Revenue Market Share by Geographic Region (2021-2026)
Table 49. Global Antipyretic Chinese Traditional Medicine Sales by Country/Region (2021-2026) & (M Units)
Table 50. Global Antipyretic Chinese Traditional Medicine Sales Market Share by Country/Region (2021-2026)
Table 51. Global Antipyretic Chinese Traditional Medicine Revenue by Country/Region (2021-2026) & ($ millions)
Table 52. Global Antipyretic Chinese Traditional Medicine Revenue Market Share by Country/Region (2021-2026)
Table 53. Americas Antipyretic Chinese Traditional Medicine Sales by Country (2021-2026) & (M Units)
Table 54. Americas Antipyretic Chinese Traditional Medicine Sales Market Share by Country (2021-2026)
Table 55. Americas Antipyretic Chinese Traditional Medicine Revenue by Country (2021-2026) & ($ millions)
Table 56. Americas Antipyretic Chinese Traditional Medicine Sales by Dosage Form (2021-2026) & (M Units)
Table 57. Americas Antipyretic Chinese Traditional Medicine Sales by Sales Channel (2021-2026) & (M Units)
Table 58. APAC Antipyretic Chinese Traditional Medicine Sales by Region (2021-2026) & (M Units)
Table 59. APAC Antipyretic Chinese Traditional Medicine Sales Market Share by Region (2021-2026)
Table 60. APAC Antipyretic Chinese Traditional Medicine Revenue by Region (2021-2026) & ($ millions)
Table 61. APAC Antipyretic Chinese Traditional Medicine Sales by Dosage Form (2021-2026) & (M Units)
Table 62. APAC Antipyretic Chinese Traditional Medicine Sales by Sales Channel (2021-2026) & (M Units)
Table 63. Europe Antipyretic Chinese Traditional Medicine Sales by Country (2021-2026) & (M Units)
Table 64. Europe Antipyretic Chinese Traditional Medicine Revenue by Country (2021-2026) & ($ millions)
Table 65. Europe Antipyretic Chinese Traditional Medicine Sales by Dosage Form (2021-2026) & (M Units)
Table 66. Europe Antipyretic Chinese Traditional Medicine Sales by Sales Channel (2021-2026) & (M Units)
Table 67. Middle East & Africa Antipyretic Chinese Traditional Medicine Sales by Country (2021-2026) & (M Units)
Table 68. Middle East & Africa Antipyretic Chinese Traditional Medicine Revenue Market Share by Country (2021-2026)
Table 69. Middle East & Africa Antipyretic Chinese Traditional Medicine Sales by Dosage Form (2021-2026) & (M Units)
Table 70. Middle East & Africa Antipyretic Chinese Traditional Medicine Sales by Sales Channel (2021-2026) & (M Units)
Table 71. Key Market Drivers & Growth Opportunities of Antipyretic Chinese Traditional Medicine
Table 72. Key Market Challenges & Risks of Antipyretic Chinese Traditional Medicine
Table 73. Key Industry Trends of Antipyretic Chinese Traditional Medicine
Table 74. Antipyretic Chinese Traditional Medicine Raw Material
Table 75. Key Suppliers of Raw Materials
Table 76. Antipyretic Chinese Traditional Medicine Distributors List
Table 77. Antipyretic Chinese Traditional Medicine Customer List
Table 78. Global Antipyretic Chinese Traditional Medicine Sales Forecast by Region (2027-2032) & (M Units)
Table 79. Global Antipyretic Chinese Traditional Medicine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 80. Americas Antipyretic Chinese Traditional Medicine Sales Forecast by Country (2027-2032) & (M Units)
Table 81. Americas Antipyretic Chinese Traditional Medicine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 82. APAC Antipyretic Chinese Traditional Medicine Sales Forecast by Region (2027-2032) & (M Units)
Table 83. APAC Antipyretic Chinese Traditional Medicine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 84. Europe Antipyretic Chinese Traditional Medicine Sales Forecast by Country (2027-2032) & (M Units)
Table 85. Europe Antipyretic Chinese Traditional Medicine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 86. Middle East & Africa Antipyretic Chinese Traditional Medicine Sales Forecast by Country (2027-2032) & (M Units)
Table 87. Middle East & Africa Antipyretic Chinese Traditional Medicine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 88. Global Antipyretic Chinese Traditional Medicine Sales Forecast by Dosage Form (2027-2032) & (M Units)
Table 89. Global Antipyretic Chinese Traditional Medicine Revenue Forecast by Dosage Form (2027-2032) & ($ millions)
Table 90. Global Antipyretic Chinese Traditional Medicine Sales Forecast by Sales Channel (2027-2032) & (M Units)
Table 91. Global Antipyretic Chinese Traditional Medicine Revenue Forecast by Sales Channel (2027-2032) & ($ millions)
Table 92. Langrun Basic Information, Antipyretic Chinese Traditional Medicine Manufacturing Base, Sales Area and Its Competitors
Table 93. Langrun Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
Table 94. Langrun Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Langrun Main Business
Table 96. Langrun Latest Developments
Table 97. Hubei Jumpcan Pharmaceutical Basic Information, Antipyretic Chinese Traditional Medicine Manufacturing Base, Sales Area and Its Competitors
Table 98. Hubei Jumpcan Pharmaceutical Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
Table 99. Hubei Jumpcan Pharmaceutical Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Hubei Jumpcan Pharmaceutical Main Business
Table 101. Hubei Jumpcan Pharmaceutical Latest Developments
Table 102. Chasesun Pharmaceutical Basic Information, Antipyretic Chinese Traditional Medicine Manufacturing Base, Sales Area and Its Competitors
Table 103. Chasesun Pharmaceutical Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
Table 104. Chasesun Pharmaceutical Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Chasesun Pharmaceutical Main Business
Table 106. Chasesun Pharmaceutical Latest Developments
Table 107. Yangtze River Pharmaceutical Basic Information, Antipyretic Chinese Traditional Medicine Manufacturing Base, Sales Area and Its Competitors
Table 108. Yangtze River Pharmaceutical Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
Table 109. Yangtze River Pharmaceutical Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Yangtze River Pharmaceutical Main Business
Table 111. Yangtze River Pharmaceutical Latest Developments
Table 112. Jiangsu Kanion Pharmaceutical Basic Information, Antipyretic Chinese Traditional Medicine Manufacturing Base, Sales Area and Its Competitors
Table 113. Jiangsu Kanion Pharmaceutical Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
Table 114. Jiangsu Kanion Pharmaceutical Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Jiangsu Kanion Pharmaceutical Main Business
Table 116. Jiangsu Kanion Pharmaceutical Latest Developments
Table 117. Guangdong Leiyunshang Basic Information, Antipyretic Chinese Traditional Medicine Manufacturing Base, Sales Area and Its Competitors
Table 118. Guangdong Leiyunshang Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
Table 119. Guangdong Leiyunshang Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Guangdong Leiyunshang Main Business
Table 121. Guangdong Leiyunshang Latest Developments
Table 122. Shineway Pharma Basic Information, Antipyretic Chinese Traditional Medicine Manufacturing Base, Sales Area and Its Competitors
Table 123. Shineway Pharma Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
Table 124. Shineway Pharma Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Shineway Pharma Main Business
Table 126. Shineway Pharma Latest Developments
Table 127. Qingfeng Pharmaceutical Basic Information, Antipyretic Chinese Traditional Medicine Manufacturing Base, Sales Area and Its Competitors
Table 128. Qingfeng Pharmaceutical Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
Table 129. Qingfeng Pharmaceutical Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. Qingfeng Pharmaceutical Main Business
Table 131. Qingfeng Pharmaceutical Latest Developments
Table 132. Jiangxi Prozin Pharmaceutical Basic Information, Antipyretic Chinese Traditional Medicine Manufacturing Base, Sales Area and Its Competitors
Table 133. Jiangxi Prozin Pharmaceutical Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
Table 134. Jiangxi Prozin Pharmaceutical Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. Jiangxi Prozin Pharmaceutical Main Business
Table 136. Jiangxi Prozin Pharmaceutical Latest Developments
Table 137. Zhenao Jinyinhua Pharmaceutical Basic Information, Antipyretic Chinese Traditional Medicine Manufacturing Base, Sales Area and Its Competitors
Table 138. Zhenao Jinyinhua Pharmaceutical Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
Table 139. Zhenao Jinyinhua Pharmaceutical Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 140. Zhenao Jinyinhua Pharmaceutical Main Business
Table 141. Zhenao Jinyinhua Pharmaceutical Latest Developments
Table 142. Shandong Runzhong Pharmaceutical Basic Information, Antipyretic Chinese Traditional Medicine Manufacturing Base, Sales Area and Its Competitors
Table 143. Shandong Runzhong Pharmaceutical Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
Table 144. Shandong Runzhong Pharmaceutical Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 145. Shandong Runzhong Pharmaceutical Main Business
Table 146. Shandong Runzhong Pharmaceutical Latest Developments
Table 147. Sinopharm Group Basic Information, Antipyretic Chinese Traditional Medicine Manufacturing Base, Sales Area and Its Competitors
Table 148. Sinopharm Group Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
Table 149. Sinopharm Group Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 150. Sinopharm Group Main Business
Table 151. Sinopharm Group Latest Developments
Table 152. Baiyunshan Mingxing Pharmaceutical Basic Information, Antipyretic Chinese Traditional Medicine Manufacturing Base, Sales Area and Its Competitors
Table 153. Baiyunshan Mingxing Pharmaceutical Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
Table 154. Baiyunshan Mingxing Pharmaceutical Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 155. Baiyunshan Mingxing Pharmaceutical Main Business
Table 156. Baiyunshan Mingxing Pharmaceutical Latest Developments
Table 157. Guangzhou Pharmaceuticals Corporation Basic Information, Antipyretic Chinese Traditional Medicine Manufacturing Base, Sales Area and Its Competitors
Table 158. Guangzhou Pharmaceuticals Corporation Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
Table 159. Guangzhou Pharmaceuticals Corporation Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 160. Guangzhou Pharmaceuticals Corporation Main Business
Table 161. Guangzhou Pharmaceuticals Corporation Latest Developments
Table 162. Yunnan Baiyao Basic Information, Antipyretic Chinese Traditional Medicine Manufacturing Base, Sales Area and Its Competitors
Table 163. Yunnan Baiyao Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
Table 164. Yunnan Baiyao Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 165. Yunnan Baiyao Main Business
Table 166. Yunnan Baiyao Latest Developments
Table 167. CR Pharmaceutical Commercial Group Basic Information, Antipyretic Chinese Traditional Medicine Manufacturing Base, Sales Area and Its Competitors
Table 168. CR Pharmaceutical Commercial Group Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
Table 169. CR Pharmaceutical Commercial Group Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 170. CR Pharmaceutical Commercial Group Main Business
Table 171. CR Pharmaceutical Commercial Group Latest Developments
Table 172. JiLin FuKang Pharmaceutical Basic Information, Antipyretic Chinese Traditional Medicine Manufacturing Base, Sales Area and Its Competitors
Table 173. JiLin FuKang Pharmaceutical Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
Table 174. JiLin FuKang Pharmaceutical Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 175. JiLin FuKang Pharmaceutical Main Business
Table 176. JiLin FuKang Pharmaceutical Latest Developments
Table 177. Zhejiang CONBA Pharmaceutical Basic Information, Antipyretic Chinese Traditional Medicine Manufacturing Base, Sales Area and Its Competitors
Table 178. Zhejiang CONBA Pharmaceutical Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
Table 179. Zhejiang CONBA Pharmaceutical Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 180. Zhejiang CONBA Pharmaceutical Main Business
Table 181. Zhejiang CONBA Pharmaceutical Latest Developments
Table 182. SemBioSys Genetics Basic Information, Antipyretic Chinese Traditional Medicine Manufacturing Base, Sales Area and Its Competitors
Table 183. SemBioSys Genetics Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
Table 184. SemBioSys Genetics Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 185. SemBioSys Genetics Main Business
Table 186. SemBioSys Genetics Latest Developments
Table 187. Wecome Pharmaceutica Basic Information, Antipyretic Chinese Traditional Medicine Manufacturing Base, Sales Area and Its Competitors
Table 188. Wecome Pharmaceutica Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
Table 189. Wecome Pharmaceutica Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 190. Wecome Pharmaceutica Main Business
Table 191. Wecome Pharmaceutica Latest Developments
Table 192. Guizhou Bailing Group Pharmaceutica Basic Information, Antipyretic Chinese Traditional Medicine Manufacturing Base, Sales Area and Its Competitors
Table 193. Guizhou Bailing Group Pharmaceutica Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
Table 194. Guizhou Bailing Group Pharmaceutica Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 195. Guizhou Bailing Group Pharmaceutica Main Business
Table 196. Guizhou Bailing Group Pharmaceutica Latest Developments
Table 197. Xiuzheng Pharmaceutical Basic Information, Antipyretic Chinese Traditional Medicine Manufacturing Base, Sales Area and Its Competitors
Table 198. Xiuzheng Pharmaceutical Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
Table 199. Xiuzheng Pharmaceutical Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 200. Xiuzheng Pharmaceutical Main Business
Table 201. Xiuzheng Pharmaceutical Latest Developments
Table 202. Taiji Basic Information, Antipyretic Chinese Traditional Medicine Manufacturing Base, Sales Area and Its Competitors
Table 203. Taiji Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
Table 204. Taiji Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 205. Taiji Main Business
Table 206. Taiji Latest Developments
Table 207. China Beijing Tong Ren Tang Group Co. Ltd. Basic Information, Antipyretic Chinese Traditional Medicine Manufacturing Base, Sales Area and Its Competitors
Table 208. China Beijing Tong Ren Tang Group Co. Ltd. Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
Table 209. China Beijing Tong Ren Tang Group Co. Ltd. Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 210. China Beijing Tong Ren Tang Group Co. Ltd. Main Business
Table 211. China Beijing Tong Ren Tang Group Co. Ltd. Latest Developments
Table 212. Kunming Pharma Basic Information, Antipyretic Chinese Traditional Medicine Manufacturing Base, Sales Area and Its Competitors
Table 213. Kunming Pharma Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
Table 214. Kunming Pharma Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 215. Kunming Pharma Main Business
Table 216. Kunming Pharma Latest Developments
Table 217. CR Sanjiu Basic Information, Antipyretic Chinese Traditional Medicine Manufacturing Base, Sales Area and Its Competitors
Table 218. CR Sanjiu Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
Table 219. CR Sanjiu Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 220. CR Sanjiu Main Business
Table 221. CR Sanjiu Latest Developments
Table 222. Yiling Pharmaceutical Basic Information, Antipyretic Chinese Traditional Medicine Manufacturing Base, Sales Area and Its Competitors
Table 223. Yiling Pharmaceutical Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
Table 224. Yiling Pharmaceutical Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 225. Yiling Pharmaceutical Main Business
Table 226. Yiling Pharmaceutical Latest Developments
Table 227. Tianjin Pharmaceutical Da Ren Tang Group Basic Information, Antipyretic Chinese Traditional Medicine Manufacturing Base, Sales Area and Its Competitors
Table 228. Tianjin Pharmaceutical Da Ren Tang Group Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
Table 229. Tianjin Pharmaceutical Da Ren Tang Group Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 230. Tianjin Pharmaceutical Da Ren Tang Group Main Business
Table 231. Tianjin Pharmaceutical Da Ren Tang Group Latest Developments
Table 232. Xiangxue Pharmaceutical Basic Information, Antipyretic Chinese Traditional Medicine Manufacturing Base, Sales Area and Its Competitors
Table 233. Xiangxue Pharmaceutical Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
Table 234. Xiangxue Pharmaceutical Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 235. Xiangxue Pharmaceutical Main Business
Table 236. Xiangxue Pharmaceutical Latest Developments
Table 237. Harbin Pharmaceutical Group Basic Information, Antipyretic Chinese Traditional Medicine Manufacturing Base, Sales Area and Its Competitors
Table 238. Harbin Pharmaceutical Group Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
Table 239. Harbin Pharmaceutical Group Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 240. Harbin Pharmaceutical Group Main Business
Table 241. Harbin Pharmaceutical Group Latest Developments
Table 242. Fusen Pharmaceutical Basic Information, Antipyretic Chinese Traditional Medicine Manufacturing Base, Sales Area and Its Competitors
Table 243. Fusen Pharmaceutical Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
Table 244. Fusen Pharmaceutical Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 245. Fusen Pharmaceutical Main Business
Table 246. Fusen Pharmaceutical Latest Developments
Table 1. Antipyretic Chinese Traditional Medicine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Antipyretic Chinese Traditional Medicine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Granule
Table 4. Major Players of Capsule
Table 5. Major Players of Tablet
Table 6. Major Players of Oral Liquid
Table 7. Major Players of Injection
Table 8. Global Antipyretic Chinese Traditional Medicine Sales by Dosage Form (2021-2026) & (M Units)
Table 9. Global Antipyretic Chinese Traditional Medicine Sales Market Share by Dosage Form (2021-2026)
Table 10. Global Antipyretic Chinese Traditional Medicine Revenue by Dosage Form (2021-2026) & ($ million)
Table 11. Global Antipyretic Chinese Traditional Medicine Revenue Market Share by Dosage Form (2021-2026)
Table 12. Global Antipyretic Chinese Traditional Medicine Sale Price by Dosage Form (2021-2026) & (US$/Unit)
Table 13. Major Players of OTC Patent Medicine
Table 14. Major Players of Prescription Patent Medicine
Table 15. Global Antipyretic Chinese Traditional Medicine Sales by Product Attribute (2021-2026) & (M Units)
Table 16. Global Antipyretic Chinese Traditional Medicine Sales Market Share by Product Attribute (2021-2026)
Table 17. Global Antipyretic Chinese Traditional Medicine Revenue by Product Attribute (2021-2026) & ($ million)
Table 18. Global Antipyretic Chinese Traditional Medicine Revenue Market Share by Product Attribute (2021-2026)
Table 19. Global Antipyretic Chinese Traditional Medicine Sale Price by Product Attribute (2021-2026) & (US$/Unit)
Table 20. Major Players of Heat-Clearing and Detoxifying
Table 21. Major Players of Wind-Heat Releasing
Table 22. Major Players of Exterior-Releasing and Antipyretic
Table 23. Major Players of Damp-Heat Clearing
Table 24. Major Players of Qi and Yin Supporting With Heat Relief
Table 25. Global Antipyretic Chinese Traditional Medicine Sales by Therapeutic Function (2021-2026) & (M Units)
Table 26. Global Antipyretic Chinese Traditional Medicine Sales Market Share by Therapeutic Function (2021-2026)
Table 27. Global Antipyretic Chinese Traditional Medicine Revenue by Therapeutic Function (2021-2026) & ($ million)
Table 28. Global Antipyretic Chinese Traditional Medicine Revenue Market Share by Therapeutic Function (2021-2026)
Table 29. Global Antipyretic Chinese Traditional Medicine Sale Price by Therapeutic Function (2021-2026) & (US$/Unit)
Table 30. Global Antipyretic Chinese Traditional Medicine Sale by Sales Channel (2021-2026) & (M Units)
Table 31. Global Antipyretic Chinese Traditional Medicine Sale Market Share by Sales Channel (2021-2026)
Table 32. Global Antipyretic Chinese Traditional Medicine Revenue by Sales Channel (2021-2026) & ($ million)
Table 33. Global Antipyretic Chinese Traditional Medicine Revenue Market Share by Sales Channel (2021-2026)
Table 34. Global Antipyretic Chinese Traditional Medicine Sale Price by Sales Channel (2021-2026) & (US$/Unit)
Table 35. Global Antipyretic Chinese Traditional Medicine Sales by Company (2021-2026) & (M Units)
Table 36. Global Antipyretic Chinese Traditional Medicine Sales Market Share by Company (2021-2026)
Table 37. Global Antipyretic Chinese Traditional Medicine Revenue by Company (2021-2026) & ($ millions)
Table 38. Global Antipyretic Chinese Traditional Medicine Revenue Market Share by Company (2021-2026)
Table 39. Global Antipyretic Chinese Traditional Medicine Sale Price by Company (2021-2026) & (US$/Unit)
Table 40. Key Manufacturers Antipyretic Chinese Traditional Medicine Producing Area Distribution and Sales Area
Table 41. Players Antipyretic Chinese Traditional Medicine Products Offered
Table 42. Antipyretic Chinese Traditional Medicine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 43. New Products and Potential Entrants
Table 44. Market M&A Activity & Strategy
Table 45. Global Antipyretic Chinese Traditional Medicine Sales by Geographic Region (2021-2026) & (M Units)
Table 46. Global Antipyretic Chinese Traditional Medicine Sales Market Share Geographic Region (2021-2026)
Table 47. Global Antipyretic Chinese Traditional Medicine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 48. Global Antipyretic Chinese Traditional Medicine Revenue Market Share by Geographic Region (2021-2026)
Table 49. Global Antipyretic Chinese Traditional Medicine Sales by Country/Region (2021-2026) & (M Units)
Table 50. Global Antipyretic Chinese Traditional Medicine Sales Market Share by Country/Region (2021-2026)
Table 51. Global Antipyretic Chinese Traditional Medicine Revenue by Country/Region (2021-2026) & ($ millions)
Table 52. Global Antipyretic Chinese Traditional Medicine Revenue Market Share by Country/Region (2021-2026)
Table 53. Americas Antipyretic Chinese Traditional Medicine Sales by Country (2021-2026) & (M Units)
Table 54. Americas Antipyretic Chinese Traditional Medicine Sales Market Share by Country (2021-2026)
Table 55. Americas Antipyretic Chinese Traditional Medicine Revenue by Country (2021-2026) & ($ millions)
Table 56. Americas Antipyretic Chinese Traditional Medicine Sales by Dosage Form (2021-2026) & (M Units)
Table 57. Americas Antipyretic Chinese Traditional Medicine Sales by Sales Channel (2021-2026) & (M Units)
Table 58. APAC Antipyretic Chinese Traditional Medicine Sales by Region (2021-2026) & (M Units)
Table 59. APAC Antipyretic Chinese Traditional Medicine Sales Market Share by Region (2021-2026)
Table 60. APAC Antipyretic Chinese Traditional Medicine Revenue by Region (2021-2026) & ($ millions)
Table 61. APAC Antipyretic Chinese Traditional Medicine Sales by Dosage Form (2021-2026) & (M Units)
Table 62. APAC Antipyretic Chinese Traditional Medicine Sales by Sales Channel (2021-2026) & (M Units)
Table 63. Europe Antipyretic Chinese Traditional Medicine Sales by Country (2021-2026) & (M Units)
Table 64. Europe Antipyretic Chinese Traditional Medicine Revenue by Country (2021-2026) & ($ millions)
Table 65. Europe Antipyretic Chinese Traditional Medicine Sales by Dosage Form (2021-2026) & (M Units)
Table 66. Europe Antipyretic Chinese Traditional Medicine Sales by Sales Channel (2021-2026) & (M Units)
Table 67. Middle East & Africa Antipyretic Chinese Traditional Medicine Sales by Country (2021-2026) & (M Units)
Table 68. Middle East & Africa Antipyretic Chinese Traditional Medicine Revenue Market Share by Country (2021-2026)
Table 69. Middle East & Africa Antipyretic Chinese Traditional Medicine Sales by Dosage Form (2021-2026) & (M Units)
Table 70. Middle East & Africa Antipyretic Chinese Traditional Medicine Sales by Sales Channel (2021-2026) & (M Units)
Table 71. Key Market Drivers & Growth Opportunities of Antipyretic Chinese Traditional Medicine
Table 72. Key Market Challenges & Risks of Antipyretic Chinese Traditional Medicine
Table 73. Key Industry Trends of Antipyretic Chinese Traditional Medicine
Table 74. Antipyretic Chinese Traditional Medicine Raw Material
Table 75. Key Suppliers of Raw Materials
Table 76. Antipyretic Chinese Traditional Medicine Distributors List
Table 77. Antipyretic Chinese Traditional Medicine Customer List
Table 78. Global Antipyretic Chinese Traditional Medicine Sales Forecast by Region (2027-2032) & (M Units)
Table 79. Global Antipyretic Chinese Traditional Medicine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 80. Americas Antipyretic Chinese Traditional Medicine Sales Forecast by Country (2027-2032) & (M Units)
Table 81. Americas Antipyretic Chinese Traditional Medicine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 82. APAC Antipyretic Chinese Traditional Medicine Sales Forecast by Region (2027-2032) & (M Units)
Table 83. APAC Antipyretic Chinese Traditional Medicine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 84. Europe Antipyretic Chinese Traditional Medicine Sales Forecast by Country (2027-2032) & (M Units)
Table 85. Europe Antipyretic Chinese Traditional Medicine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 86. Middle East & Africa Antipyretic Chinese Traditional Medicine Sales Forecast by Country (2027-2032) & (M Units)
Table 87. Middle East & Africa Antipyretic Chinese Traditional Medicine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 88. Global Antipyretic Chinese Traditional Medicine Sales Forecast by Dosage Form (2027-2032) & (M Units)
Table 89. Global Antipyretic Chinese Traditional Medicine Revenue Forecast by Dosage Form (2027-2032) & ($ millions)
Table 90. Global Antipyretic Chinese Traditional Medicine Sales Forecast by Sales Channel (2027-2032) & (M Units)
Table 91. Global Antipyretic Chinese Traditional Medicine Revenue Forecast by Sales Channel (2027-2032) & ($ millions)
Table 92. Langrun Basic Information, Antipyretic Chinese Traditional Medicine Manufacturing Base, Sales Area and Its Competitors
Table 93. Langrun Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
Table 94. Langrun Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Langrun Main Business
Table 96. Langrun Latest Developments
Table 97. Hubei Jumpcan Pharmaceutical Basic Information, Antipyretic Chinese Traditional Medicine Manufacturing Base, Sales Area and Its Competitors
Table 98. Hubei Jumpcan Pharmaceutical Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
Table 99. Hubei Jumpcan Pharmaceutical Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Hubei Jumpcan Pharmaceutical Main Business
Table 101. Hubei Jumpcan Pharmaceutical Latest Developments
Table 102. Chasesun Pharmaceutical Basic Information, Antipyretic Chinese Traditional Medicine Manufacturing Base, Sales Area and Its Competitors
Table 103. Chasesun Pharmaceutical Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
Table 104. Chasesun Pharmaceutical Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Chasesun Pharmaceutical Main Business
Table 106. Chasesun Pharmaceutical Latest Developments
Table 107. Yangtze River Pharmaceutical Basic Information, Antipyretic Chinese Traditional Medicine Manufacturing Base, Sales Area and Its Competitors
Table 108. Yangtze River Pharmaceutical Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
Table 109. Yangtze River Pharmaceutical Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Yangtze River Pharmaceutical Main Business
Table 111. Yangtze River Pharmaceutical Latest Developments
Table 112. Jiangsu Kanion Pharmaceutical Basic Information, Antipyretic Chinese Traditional Medicine Manufacturing Base, Sales Area and Its Competitors
Table 113. Jiangsu Kanion Pharmaceutical Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
Table 114. Jiangsu Kanion Pharmaceutical Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Jiangsu Kanion Pharmaceutical Main Business
Table 116. Jiangsu Kanion Pharmaceutical Latest Developments
Table 117. Guangdong Leiyunshang Basic Information, Antipyretic Chinese Traditional Medicine Manufacturing Base, Sales Area and Its Competitors
Table 118. Guangdong Leiyunshang Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
Table 119. Guangdong Leiyunshang Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Guangdong Leiyunshang Main Business
Table 121. Guangdong Leiyunshang Latest Developments
Table 122. Shineway Pharma Basic Information, Antipyretic Chinese Traditional Medicine Manufacturing Base, Sales Area and Its Competitors
Table 123. Shineway Pharma Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
Table 124. Shineway Pharma Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Shineway Pharma Main Business
Table 126. Shineway Pharma Latest Developments
Table 127. Qingfeng Pharmaceutical Basic Information, Antipyretic Chinese Traditional Medicine Manufacturing Base, Sales Area and Its Competitors
Table 128. Qingfeng Pharmaceutical Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
Table 129. Qingfeng Pharmaceutical Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. Qingfeng Pharmaceutical Main Business
Table 131. Qingfeng Pharmaceutical Latest Developments
Table 132. Jiangxi Prozin Pharmaceutical Basic Information, Antipyretic Chinese Traditional Medicine Manufacturing Base, Sales Area and Its Competitors
Table 133. Jiangxi Prozin Pharmaceutical Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
Table 134. Jiangxi Prozin Pharmaceutical Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. Jiangxi Prozin Pharmaceutical Main Business
Table 136. Jiangxi Prozin Pharmaceutical Latest Developments
Table 137. Zhenao Jinyinhua Pharmaceutical Basic Information, Antipyretic Chinese Traditional Medicine Manufacturing Base, Sales Area and Its Competitors
Table 138. Zhenao Jinyinhua Pharmaceutical Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
Table 139. Zhenao Jinyinhua Pharmaceutical Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 140. Zhenao Jinyinhua Pharmaceutical Main Business
Table 141. Zhenao Jinyinhua Pharmaceutical Latest Developments
Table 142. Shandong Runzhong Pharmaceutical Basic Information, Antipyretic Chinese Traditional Medicine Manufacturing Base, Sales Area and Its Competitors
Table 143. Shandong Runzhong Pharmaceutical Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
Table 144. Shandong Runzhong Pharmaceutical Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 145. Shandong Runzhong Pharmaceutical Main Business
Table 146. Shandong Runzhong Pharmaceutical Latest Developments
Table 147. Sinopharm Group Basic Information, Antipyretic Chinese Traditional Medicine Manufacturing Base, Sales Area and Its Competitors
Table 148. Sinopharm Group Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
Table 149. Sinopharm Group Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 150. Sinopharm Group Main Business
Table 151. Sinopharm Group Latest Developments
Table 152. Baiyunshan Mingxing Pharmaceutical Basic Information, Antipyretic Chinese Traditional Medicine Manufacturing Base, Sales Area and Its Competitors
Table 153. Baiyunshan Mingxing Pharmaceutical Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
Table 154. Baiyunshan Mingxing Pharmaceutical Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 155. Baiyunshan Mingxing Pharmaceutical Main Business
Table 156. Baiyunshan Mingxing Pharmaceutical Latest Developments
Table 157. Guangzhou Pharmaceuticals Corporation Basic Information, Antipyretic Chinese Traditional Medicine Manufacturing Base, Sales Area and Its Competitors
Table 158. Guangzhou Pharmaceuticals Corporation Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
Table 159. Guangzhou Pharmaceuticals Corporation Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 160. Guangzhou Pharmaceuticals Corporation Main Business
Table 161. Guangzhou Pharmaceuticals Corporation Latest Developments
Table 162. Yunnan Baiyao Basic Information, Antipyretic Chinese Traditional Medicine Manufacturing Base, Sales Area and Its Competitors
Table 163. Yunnan Baiyao Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
Table 164. Yunnan Baiyao Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 165. Yunnan Baiyao Main Business
Table 166. Yunnan Baiyao Latest Developments
Table 167. CR Pharmaceutical Commercial Group Basic Information, Antipyretic Chinese Traditional Medicine Manufacturing Base, Sales Area and Its Competitors
Table 168. CR Pharmaceutical Commercial Group Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
Table 169. CR Pharmaceutical Commercial Group Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 170. CR Pharmaceutical Commercial Group Main Business
Table 171. CR Pharmaceutical Commercial Group Latest Developments
Table 172. JiLin FuKang Pharmaceutical Basic Information, Antipyretic Chinese Traditional Medicine Manufacturing Base, Sales Area and Its Competitors
Table 173. JiLin FuKang Pharmaceutical Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
Table 174. JiLin FuKang Pharmaceutical Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 175. JiLin FuKang Pharmaceutical Main Business
Table 176. JiLin FuKang Pharmaceutical Latest Developments
Table 177. Zhejiang CONBA Pharmaceutical Basic Information, Antipyretic Chinese Traditional Medicine Manufacturing Base, Sales Area and Its Competitors
Table 178. Zhejiang CONBA Pharmaceutical Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
Table 179. Zhejiang CONBA Pharmaceutical Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 180. Zhejiang CONBA Pharmaceutical Main Business
Table 181. Zhejiang CONBA Pharmaceutical Latest Developments
Table 182. SemBioSys Genetics Basic Information, Antipyretic Chinese Traditional Medicine Manufacturing Base, Sales Area and Its Competitors
Table 183. SemBioSys Genetics Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
Table 184. SemBioSys Genetics Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 185. SemBioSys Genetics Main Business
Table 186. SemBioSys Genetics Latest Developments
Table 187. Wecome Pharmaceutica Basic Information, Antipyretic Chinese Traditional Medicine Manufacturing Base, Sales Area and Its Competitors
Table 188. Wecome Pharmaceutica Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
Table 189. Wecome Pharmaceutica Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 190. Wecome Pharmaceutica Main Business
Table 191. Wecome Pharmaceutica Latest Developments
Table 192. Guizhou Bailing Group Pharmaceutica Basic Information, Antipyretic Chinese Traditional Medicine Manufacturing Base, Sales Area and Its Competitors
Table 193. Guizhou Bailing Group Pharmaceutica Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
Table 194. Guizhou Bailing Group Pharmaceutica Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 195. Guizhou Bailing Group Pharmaceutica Main Business
Table 196. Guizhou Bailing Group Pharmaceutica Latest Developments
Table 197. Xiuzheng Pharmaceutical Basic Information, Antipyretic Chinese Traditional Medicine Manufacturing Base, Sales Area and Its Competitors
Table 198. Xiuzheng Pharmaceutical Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
Table 199. Xiuzheng Pharmaceutical Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 200. Xiuzheng Pharmaceutical Main Business
Table 201. Xiuzheng Pharmaceutical Latest Developments
Table 202. Taiji Basic Information, Antipyretic Chinese Traditional Medicine Manufacturing Base, Sales Area and Its Competitors
Table 203. Taiji Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
Table 204. Taiji Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 205. Taiji Main Business
Table 206. Taiji Latest Developments
Table 207. China Beijing Tong Ren Tang Group Co. Ltd. Basic Information, Antipyretic Chinese Traditional Medicine Manufacturing Base, Sales Area and Its Competitors
Table 208. China Beijing Tong Ren Tang Group Co. Ltd. Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
Table 209. China Beijing Tong Ren Tang Group Co. Ltd. Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 210. China Beijing Tong Ren Tang Group Co. Ltd. Main Business
Table 211. China Beijing Tong Ren Tang Group Co. Ltd. Latest Developments
Table 212. Kunming Pharma Basic Information, Antipyretic Chinese Traditional Medicine Manufacturing Base, Sales Area and Its Competitors
Table 213. Kunming Pharma Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
Table 214. Kunming Pharma Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 215. Kunming Pharma Main Business
Table 216. Kunming Pharma Latest Developments
Table 217. CR Sanjiu Basic Information, Antipyretic Chinese Traditional Medicine Manufacturing Base, Sales Area and Its Competitors
Table 218. CR Sanjiu Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
Table 219. CR Sanjiu Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 220. CR Sanjiu Main Business
Table 221. CR Sanjiu Latest Developments
Table 222. Yiling Pharmaceutical Basic Information, Antipyretic Chinese Traditional Medicine Manufacturing Base, Sales Area and Its Competitors
Table 223. Yiling Pharmaceutical Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
Table 224. Yiling Pharmaceutical Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 225. Yiling Pharmaceutical Main Business
Table 226. Yiling Pharmaceutical Latest Developments
Table 227. Tianjin Pharmaceutical Da Ren Tang Group Basic Information, Antipyretic Chinese Traditional Medicine Manufacturing Base, Sales Area and Its Competitors
Table 228. Tianjin Pharmaceutical Da Ren Tang Group Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
Table 229. Tianjin Pharmaceutical Da Ren Tang Group Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 230. Tianjin Pharmaceutical Da Ren Tang Group Main Business
Table 231. Tianjin Pharmaceutical Da Ren Tang Group Latest Developments
Table 232. Xiangxue Pharmaceutical Basic Information, Antipyretic Chinese Traditional Medicine Manufacturing Base, Sales Area and Its Competitors
Table 233. Xiangxue Pharmaceutical Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
Table 234. Xiangxue Pharmaceutical Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 235. Xiangxue Pharmaceutical Main Business
Table 236. Xiangxue Pharmaceutical Latest Developments
Table 237. Harbin Pharmaceutical Group Basic Information, Antipyretic Chinese Traditional Medicine Manufacturing Base, Sales Area and Its Competitors
Table 238. Harbin Pharmaceutical Group Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
Table 239. Harbin Pharmaceutical Group Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 240. Harbin Pharmaceutical Group Main Business
Table 241. Harbin Pharmaceutical Group Latest Developments
Table 242. Fusen Pharmaceutical Basic Information, Antipyretic Chinese Traditional Medicine Manufacturing Base, Sales Area and Its Competitors
Table 243. Fusen Pharmaceutical Antipyretic Chinese Traditional Medicine Product Portfolios and Specifications
Table 244. Fusen Pharmaceutical Antipyretic Chinese Traditional Medicine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 245. Fusen Pharmaceutical Main Business
Table 246. Fusen Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. Picture of Antipyretic Chinese Traditional Medicine
Figure 2. Antipyretic Chinese Traditional Medicine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Antipyretic Chinese Traditional Medicine Sales Growth Rate 2021-2032 (M Units)
Figure 7. Global Antipyretic Chinese Traditional Medicine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Antipyretic Chinese Traditional Medicine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Antipyretic Chinese Traditional Medicine Sales Market Share by Country/Region (2025)
Figure 10. Antipyretic Chinese Traditional Medicine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Granule
Figure 12. Product Picture of Capsule
Figure 13. Product Picture of Tablet
Figure 14. Product Picture of Oral Liquid
Figure 15. Product Picture of Injection
Figure 16. Global Antipyretic Chinese Traditional Medicine Sales Market Share by Dosage Form in 2026
Figure 17. Global Antipyretic Chinese Traditional Medicine Revenue Market Share by Dosage Form (2021-2026)
Figure 18. Product Picture of OTC Patent Medicine
Figure 19. Product Picture of Prescription Patent Medicine
Figure 20. Global Antipyretic Chinese Traditional Medicine Sales Market Share by Product Attribute in 2026
Figure 21. Global Antipyretic Chinese Traditional Medicine Revenue Market Share by Product Attribute (2021-2026)
Figure 22. Product Picture of Heat-Clearing and Detoxifying
Figure 23. Product Picture of Wind-Heat Releasing
Figure 24. Product Picture of Exterior-Releasing and Antipyretic
Figure 25. Product Picture of Damp-Heat Clearing
Figure 26. Product Picture of Qi and Yin Supporting With Heat Relief
Figure 27. Global Antipyretic Chinese Traditional Medicine Sales Market Share by Therapeutic Function in 2026
Figure 28. Global Antipyretic Chinese Traditional Medicine Revenue Market Share by Therapeutic Function (2021-2026)
Figure 29. Antipyretic Chinese Traditional Medicine Consumed in Online Sales
Figure 30. Global Antipyretic Chinese Traditional Medicine Market: Online Sales (2021-2026) & (M Units)
Figure 31. Antipyretic Chinese Traditional Medicine Consumed in Offline Sales
Figure 32. Global Antipyretic Chinese Traditional Medicine Market: Offline Sales (2021-2026) & (M Units)
Figure 33. Global Antipyretic Chinese Traditional Medicine Sale Market Share by Sales Channel (2025)
Figure 34. Global Antipyretic Chinese Traditional Medicine Revenue Market Share by Sales Channel in 2026
Figure 35. Antipyretic Chinese Traditional Medicine Sales by Company in 2026 (M Units)
Figure 36. Global Antipyretic Chinese Traditional Medicine Sales Market Share by Company in 2026
Figure 37. Antipyretic Chinese Traditional Medicine Revenue by Company in 2026 ($ millions)
Figure 38. Global Antipyretic Chinese Traditional Medicine Revenue Market Share by Company in 2026
Figure 39. Global Antipyretic Chinese Traditional Medicine Sales Market Share by Geographic Region (2021-2026)
Figure 40. Global Antipyretic Chinese Traditional Medicine Revenue Market Share by Geographic Region in 2026
Figure 41. Americas Antipyretic Chinese Traditional Medicine Sales 2021-2026 (M Units)
Figure 42. Americas Antipyretic Chinese Traditional Medicine Revenue 2021-2026 ($ millions)
Figure 43. APAC Antipyretic Chinese Traditional Medicine Sales 2021-2026 (M Units)
Figure 44. APAC Antipyretic Chinese Traditional Medicine Revenue 2021-2026 ($ millions)
Figure 45. Europe Antipyretic Chinese Traditional Medicine Sales 2021-2026 (M Units)
Figure 46. Europe Antipyretic Chinese Traditional Medicine Revenue 2021-2026 ($ millions)
Figure 47. Middle East & Africa Antipyretic Chinese Traditional Medicine Sales 2021-2026 (M Units)
Figure 48. Middle East & Africa Antipyretic Chinese Traditional Medicine Revenue 2021-2026 ($ millions)
Figure 49. Americas Antipyretic Chinese Traditional Medicine Sales Market Share by Country in 2026
Figure 50. Americas Antipyretic Chinese Traditional Medicine Revenue Market Share by Country (2021-2026)
Figure 51. Americas Antipyretic Chinese Traditional Medicine Sales Market Share by Dosage Form (2021-2026)
Figure 52. Americas Antipyretic Chinese Traditional Medicine Sales Market Share by Sales Channel (2021-2026)
Figure 53. United States Antipyretic Chinese Traditional Medicine Revenue Growth 2021-2026 ($ millions)
Figure 54. Canada Antipyretic Chinese Traditional Medicine Revenue Growth 2021-2026 ($ millions)
Figure 55. Mexico Antipyretic Chinese Traditional Medicine Revenue Growth 2021-2026 ($ millions)
Figure 56. Brazil Antipyretic Chinese Traditional Medicine Revenue Growth 2021-2026 ($ millions)
Figure 57. APAC Antipyretic Chinese Traditional Medicine Sales Market Share by Region in 2026
Figure 58. APAC Antipyretic Chinese Traditional Medicine Revenue Market Share by Region (2021-2026)
Figure 59. APAC Antipyretic Chinese Traditional Medicine Sales Market Share by Dosage Form (2021-2026)
Figure 60. APAC Antipyretic Chinese Traditional Medicine Sales Market Share by Sales Channel (2021-2026)
Figure 61. China Antipyretic Chinese Traditional Medicine Revenue Growth 2021-2026 ($ millions)
Figure 62. Japan Antipyretic Chinese Traditional Medicine Revenue Growth 2021-2026 ($ millions)
Figure 63. South Korea Antipyretic Chinese Traditional Medicine Revenue Growth 2021-2026 ($ millions)
Figure 64. Southeast Asia Antipyretic Chinese Traditional Medicine Revenue Growth 2021-2026 ($ millions)
Figure 65. India Antipyretic Chinese Traditional Medicine Revenue Growth 2021-2026 ($ millions)
Figure 66. Australia Antipyretic Chinese Traditional Medicine Revenue Growth 2021-2026 ($ millions)
Figure 67. China Taiwan Antipyretic Chinese Traditional Medicine Revenue Growth 2021-2026 ($ millions)
Figure 68. Europe Antipyretic Chinese Traditional Medicine Sales Market Share by Country in 2026
Figure 69. Europe Antipyretic Chinese Traditional Medicine Revenue Market Share by Country (2021-2026)
Figure 70. Europe Antipyretic Chinese Traditional Medicine Sales Market Share by Dosage Form (2021-2026)
Figure 71. Europe Antipyretic Chinese Traditional Medicine Sales Market Share by Sales Channel (2021-2026)
Figure 72. Germany Antipyretic Chinese Traditional Medicine Revenue Growth 2021-2026 ($ millions)
Figure 73. France Antipyretic Chinese Traditional Medicine Revenue Growth 2021-2026 ($ millions)
Figure 74. UK Antipyretic Chinese Traditional Medicine Revenue Growth 2021-2026 ($ millions)
Figure 75. Italy Antipyretic Chinese Traditional Medicine Revenue Growth 2021-2026 ($ millions)
Figure 76. Russia Antipyretic Chinese Traditional Medicine Revenue Growth 2021-2026 ($ millions)
Figure 77. Middle East & Africa Antipyretic Chinese Traditional Medicine Sales Market Share by Country (2021-2026)
Figure 1. Picture of Antipyretic Chinese Traditional Medicine
Figure 2. Antipyretic Chinese Traditional Medicine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Antipyretic Chinese Traditional Medicine Sales Growth Rate 2021-2032 (M Units)
Figure 7. Global Antipyretic Chinese Traditional Medicine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Antipyretic Chinese Traditional Medicine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Antipyretic Chinese Traditional Medicine Sales Market Share by Country/Region (2025)
Figure 10. Antipyretic Chinese Traditional Medicine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Granule
Figure 12. Product Picture of Capsule
Figure 13. Product Picture of Tablet
Figure 14. Product Picture of Oral Liquid
Figure 15. Product Picture of Injection
Figure 16. Global Antipyretic Chinese Traditional Medicine Sales Market Share by Dosage Form in 2026
Figure 17. Global Antipyretic Chinese Traditional Medicine Revenue Market Share by Dosage Form (2021-2026)
Figure 18. Product Picture of OTC Patent Medicine
Figure 19. Product Picture of Prescription Patent Medicine
Figure 20. Global Antipyretic Chinese Traditional Medicine Sales Market Share by Product Attribute in 2026
Figure 21. Global Antipyretic Chinese Traditional Medicine Revenue Market Share by Product Attribute (2021-2026)
Figure 22. Product Picture of Heat-Clearing and Detoxifying
Figure 23. Product Picture of Wind-Heat Releasing
Figure 24. Product Picture of Exterior-Releasing and Antipyretic
Figure 25. Product Picture of Damp-Heat Clearing
Figure 26. Product Picture of Qi and Yin Supporting With Heat Relief
Figure 27. Global Antipyretic Chinese Traditional Medicine Sales Market Share by Therapeutic Function in 2026
Figure 28. Global Antipyretic Chinese Traditional Medicine Revenue Market Share by Therapeutic Function (2021-2026)
Figure 29. Antipyretic Chinese Traditional Medicine Consumed in Online Sales
Figure 30. Global Antipyretic Chinese Traditional Medicine Market: Online Sales (2021-2026) & (M Units)
Figure 31. Antipyretic Chinese Traditional Medicine Consumed in Offline Sales
Figure 32. Global Antipyretic Chinese Traditional Medicine Market: Offline Sales (2021-2026) & (M Units)
Figure 33. Global Antipyretic Chinese Traditional Medicine Sale Market Share by Sales Channel (2025)
Figure 34. Global Antipyretic Chinese Traditional Medicine Revenue Market Share by Sales Channel in 2026
Figure 35. Antipyretic Chinese Traditional Medicine Sales by Company in 2026 (M Units)
Figure 36. Global Antipyretic Chinese Traditional Medicine Sales Market Share by Company in 2026
Figure 37. Antipyretic Chinese Traditional Medicine Revenue by Company in 2026 ($ millions)
Figure 38. Global Antipyretic Chinese Traditional Medicine Revenue Market Share by Company in 2026
Figure 39. Global Antipyretic Chinese Traditional Medicine Sales Market Share by Geographic Region (2021-2026)
Figure 40. Global Antipyretic Chinese Traditional Medicine Revenue Market Share by Geographic Region in 2026
Figure 41. Americas Antipyretic Chinese Traditional Medicine Sales 2021-2026 (M Units)
Figure 42. Americas Antipyretic Chinese Traditional Medicine Revenue 2021-2026 ($ millions)
Figure 43. APAC Antipyretic Chinese Traditional Medicine Sales 2021-2026 (M Units)
Figure 44. APAC Antipyretic Chinese Traditional Medicine Revenue 2021-2026 ($ millions)
Figure 45. Europe Antipyretic Chinese Traditional Medicine Sales 2021-2026 (M Units)
Figure 46. Europe Antipyretic Chinese Traditional Medicine Revenue 2021-2026 ($ millions)
Figure 47. Middle East & Africa Antipyretic Chinese Traditional Medicine Sales 2021-2026 (M Units)
Figure 48. Middle East & Africa Antipyretic Chinese Traditional Medicine Revenue 2021-2026 ($ millions)
Figure 49. Americas Antipyretic Chinese Traditional Medicine Sales Market Share by Country in 2026
Figure 50. Americas Antipyretic Chinese Traditional Medicine Revenue Market Share by Country (2021-2026)
Figure 51. Americas Antipyretic Chinese Traditional Medicine Sales Market Share by Dosage Form (2021-2026)
Figure 52. Americas Antipyretic Chinese Traditional Medicine Sales Market Share by Sales Channel (2021-2026)
Figure 53. United States Antipyretic Chinese Traditional Medicine Revenue Growth 2021-2026 ($ millions)
Figure 54. Canada Antipyretic Chinese Traditional Medicine Revenue Growth 2021-2026 ($ millions)
Figure 55. Mexico Antipyretic Chinese Traditional Medicine Revenue Growth 2021-2026 ($ millions)
Figure 56. Brazil Antipyretic Chinese Traditional Medicine Revenue Growth 2021-2026 ($ millions)
Figure 57. APAC Antipyretic Chinese Traditional Medicine Sales Market Share by Region in 2026
Figure 58. APAC Antipyretic Chinese Traditional Medicine Revenue Market Share by Region (2021-2026)
Figure 59. APAC Antipyretic Chinese Traditional Medicine Sales Market Share by Dosage Form (2021-2026)
Figure 60. APAC Antipyretic Chinese Traditional Medicine Sales Market Share by Sales Channel (2021-2026)
Figure 61. China Antipyretic Chinese Traditional Medicine Revenue Growth 2021-2026 ($ millions)
Figure 62. Japan Antipyretic Chinese Traditional Medicine Revenue Growth 2021-2026 ($ millions)
Figure 63. South Korea Antipyretic Chinese Traditional Medicine Revenue Growth 2021-2026 ($ millions)
Figure 64. Southeast Asia Antipyretic Chinese Traditional Medicine Revenue Growth 2021-2026 ($ millions)
Figure 65. India Antipyretic Chinese Traditional Medicine Revenue Growth 2021-2026 ($ millions)
Figure 66. Australia Antipyretic Chinese Traditional Medicine Revenue Growth 2021-2026 ($ millions)
Figure 67. China Taiwan Antipyretic Chinese Traditional Medicine Revenue Growth 2021-2026 ($ millions)
Figure 68. Europe Antipyretic Chinese Traditional Medicine Sales Market Share by Country in 2026
Figure 69. Europe Antipyretic Chinese Traditional Medicine Revenue Market Share by Country (2021-2026)
Figure 70. Europe Antipyretic Chinese Traditional Medicine Sales Market Share by Dosage Form (2021-2026)
Figure 71. Europe Antipyretic Chinese Traditional Medicine Sales Market Share by Sales Channel (2021-2026)
Figure 72. Germany Antipyretic Chinese Traditional Medicine Revenue Growth 2021-2026 ($ millions)
Figure 73. France Antipyretic Chinese Traditional Medicine Revenue Growth 2021-2026 ($ millions)
Figure 74. UK Antipyretic Chinese Traditional Medicine Revenue Growth 2021-2026 ($ millions)
Figure 75. Italy Antipyretic Chinese Traditional Medicine Revenue Growth 2021-2026 ($ millions)
Figure 76. Russia Antipyretic Chinese Traditional Medicine Revenue Growth 2021-2026 ($ millions)
Figure 77. Middle East & Africa Antipyretic Chinese Traditional Medicine Sales Market Share by Country (2021-2026)
